나이벡

138610KOSDAQ

52.9 / 100

Reference Date: 2026-09-08

Financial Score18.0 / 40

News Sentiment20.9 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 2.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Nabix operates in the fields of bio-regenerative materials, peptide pharmaceuticals, and oral health products, holding global certifications such as FDA, CE, and NMPA, and selling products worldwide. The company is focusing on expanding its global market through the commercialization of new products like PeptiCol EZgraft and obtaining European MDR certification, while also developing early diagnosis kits and treatments for periodontal diseases.

Number of Employees

93people

Average Salary

59.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

36.42Industry Average 15.000.0Point

2.4x industry avg (risky)

PBR

3.76Industry Average 1.200.0Point

3.1x industry avg (risky)

ROE

11.89Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

11.70Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲44.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲40.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.0% (improving, 3yr)

Detailed News Sentiment

8 totalPositive 8Neutral 0Negative 0Average Sentiment Score 83.8

Positive
나이벡, 수의치과 재생소재 시장 공략…아시아수의치과포럼 참가
나이벡의 치과용 재생소재 기술이 아시아수의치과포럼에서 소개되며 시장 진출 기회 확대 기대.
Positive
[굿브레인 2026]"GLP-1, 뇌질환 치료 블록버스터 가능"…전문가...
나이벡의 GLP-1 기반 치료제가 뇌질환 치료제로서 상용화 가능성이 높게 평가되어 긍정적인 시장 반응 예상.
Positive
[굿브레인 2026]박윤정 나이벡 부사장 "펩타이드 가능성 무궁무진…'...
나이벡의 박윤정 부사장이 펩타이드 연구의 잠재력을 강조하며 BBB 투과율 향상과 다중 작용제 개발을 통한 경쟁력 강화를 언급해 긍정적인 전망을 제시했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (7%, downtrend)

Current 15,150Won52-week high 52,30052-week low 12,200

1-month return2.0Point

1m -2.01% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-08-24
Neutral반기보고서 (2026.06)2026-08-14